Search Results - "Samelis, Georgios"
-
1
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental
Published in Anticancer research (01-01-2020)“…Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according…”
Get full text
Journal Article -
2
Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations
Published in Journal of cardiovascular medicine (Hagerstown, Md.) (01-08-2008)“…Cardiac neoplasms, whether primary or secondary, are more and more easily diagnosed in the present era. For the primary heart tumors, myxomas and sarcomas…”
Get full text
Journal Article -
3
The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit
Published in Hepato-gastroenterology (01-11-2011)“…There is little information in the literature on the use of bevacizumab (BV) combination chemotherapy in multiple lines with regimens including irinotecan and…”
Get more information
Journal Article -
4
Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients
Published in Hepato-gastroenterology (01-09-2011)“…Although research on new effective treatments against pancreatic cancer is intense, limited therapeutic schemes are currently approved. The aim of the present…”
Get more information
Journal Article -
5
Small-cell lung cancer: an unusual therapeutic approach with more than 10-year overall survival. Case report and review of the literature
Published in Tumori (01-07-2008)“…Small-cell lung cancer is the most aggressive lung cancer, with a dismal prognosis. The authors present a case report of a patient with limited-stage…”
Get full text
Journal Article -
6
Real world data for venous thromboembolisms (VTEs) in patients with active cancer: Thromboprophylaxis pooled analysis from GMaT and ACT4CAT studies
Published in Journal of clinical oncology (01-06-2023)“…6637 Background: Venous Thromboembolisms (VTEs) lead to many negative consequences for patients with active cancer and are reported up to 20%. They affect…”
Get full text
Journal Article -
7
Prevention of venous thromboembolism in ambulatory patients with active cancer: Results from ACT4CAT study
Published in Journal of clinical oncology (01-06-2022)“…e18677 Background: Venous ThromboEmbolism (VTE), might be a challenge with a lot of negative consequences for patients with active cancer. VTE affects ongoing…”
Get full text
Journal Article -
8
Thromboprophylaxis in active cancer patients: Is it a controversial clinical issue or not? Preliminary results of ACT4CAT study
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e18803 Background: Cancer Associated Thrombosis (CAT) is an increasing challenge for oncology patients since oncologists sometimes are reluctant…”
Get full text
Journal Article -
9
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
Published in Cancers (09-06-2021)“…Pancreatic cancer (PaC) induces a prothrombotic and hypercoagulable state. The aim of this study was to investigate the effect of tinzaparin in combination…”
Get full text
Journal Article -
10
ACT for prevention and prophylaxis of cancer-associated thrombosis (CAT)
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e14135 Background: CAT is the 2 nd leading cause of death in oncology patients and there is need for thrombosis management across the natural…”
Get full text
Journal Article -
11
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients' Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece
Published in Cancers (08-04-2022)“…This non-interventional, multicenter, prospective study aimed to evaluate the real-world activity of trabectedin, and its impact on symptom burden and quality…”
Get full text
Journal Article -
12
Is cancer associated thrombosis (CAT) an underestimated issue in oncology clinical practice? Real-world data regarding long term management of CAT
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e23150 Background: Cancer is associated with thrombosis due to different pathophysiological processes. CAT is the 2 nd cause of death in oncology…”
Get full text
Journal Article -
13
Prophylaxis of cancer‑associated venous thromboembolism with low‑molecular‑weight heparin‑tinzaparin: Real world evidence
Published in Oncology letters (01-04-2022)“…Thromboprophylaxis, as a preventive measure for cancer-associated thrombosis (CAT), may be beneficial for patients with active cancer and high-risk for…”
Get full text
Journal Article -
14
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Published in Cancers (15-07-2020)“…Background: Cancer patients are at high risk for cancer-associated thrombosis (CAT). CAT is the second leading cause of death in these patients but it can be…”
Get full text
Journal Article -
15
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group
Published in Urology (Ridgewood, N.J.) (01-08-2005)“…To evaluate the safety profile and therapeutic value of the combination of estramustine, mitoxantrone, and vinorelbine in the treatment of hormone-refractory…”
Get full text
Journal Article